Skip to content
Recall Observatory FDA recall evidence

Drug product

AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454. NDC: 0093-4161-73

D-0165-2024

January 26, 2022

Class II

Product summary

Firm
CARDINAL HEALTHCARE
Event
Event 89450
Status
Terminated
Classification
Class II
Quantity
3 units
Official record key
drug-enforcement:D-0165-2024

Official wording

Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Code information: Batch 35447184A

Distribution pattern: Nationwide USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations